mRNA Neoantigen Vaccine(Shanghai Children's Medical Center)

N/A

Report date: 2026/05/13 09:07:48

Base Information

Drug NamemRNA Neoantigen Vaccine(Shanghai Children's Medical Center)
Drug Alias Nameindividualized mRNA neoantigen vaccine(Shanghai Children's Medical Center)mRNA-0523-L001
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccinesVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMedullary thyroid cancer (MTC)Adrenocortical CarcinomaAdenoma, Islet Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShanghai Children'S Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Children'S Medical Center
Inactive CompaniesN/A
Active IndicationsMedullary thyroid cancer (MTC)Adrenocortical CarcinomaAdenoma, Islet Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A